180 related articles for article (PubMed ID: 34105220)
21. The molecular weight-dependent distribution of urinary glycosaminoglycans in Werner's syndrome.
Murata K
Biochem Med; 1985 Dec; 34(3):251-8. PubMed ID: 3938279
[TBL] [Abstract][Full Text] [Related]
22. Lack of effect of caffeine post-treatment on X-ray-induced chromosomal aberrations in Werner's syndrome lymphoblastoid cell lines: a preliminary report.
Franchitto A; Proietti De Santis L; Pichierri P; Mosesso P; Palitti F
Int J Radiat Biol; 1999 Nov; 75(11):1349-55. PubMed ID: 10597909
[TBL] [Abstract][Full Text] [Related]
23. Computational analyses of the catalytic and heparin-binding sites and their interactions with glycosaminoglycans in glycoside hydrolase family 79 endo-β-D-glucuronidase (heparanase).
Gandhi NS; Freeman C; Parish CR; Mancera RL
Glycobiology; 2012 Jan; 22(1):35-55. PubMed ID: 21746763
[TBL] [Abstract][Full Text] [Related]
24. Turnover of sulfated glycosaminoglycans in fibroblasts derived from patients with Werner's syndrome.
Cowles EA; Brauker JH; Anderson RL
Exp Cell Res; 1987 Feb; 168(2):347-57. PubMed ID: 3100317
[TBL] [Abstract][Full Text] [Related]
25. Hyaluronate synthesized by cultured skin fibroblasts derived from patients with Werner's syndrome.
Nakamura T; Takagaki K; Kubo K; Saito T; Endo M; Mori S; Morisaki N; Saito Y; Yoshida S
Biochim Biophys Acta; 1992 Jun; 1139(1-2):84-90. PubMed ID: 1610921
[TBL] [Abstract][Full Text] [Related]
26. Cell surface changes in senescent and Werner's syndrome fibroblasts: their role in cell proliferation.
Mitsui Y; Yamamoto K; Yamamoto M; Matuoka K
Adv Exp Med Biol; 1985; 190():567-85. PubMed ID: 4083164
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of Cytomegalovirus Replication with Extended-Half-Life Synthetic Ozonides.
Wang Y; Mukhopadhyay R; Roy S; Kapoor A; Su YP; Charman SA; Chen G; Wu J; Wang X; Vennerstrom JL; Arav-Boger R
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373792
[TBL] [Abstract][Full Text] [Related]
28. 4"-Benzoylureido-TSAO derivatives as potent and selective non-nucleoside HCMV inhibitors. Structure-activity relationship and mechanism of antiviral action.
de Castro S; Peromingo MT; Naesens L; Andrei G; Snoeck R; Balzarini J; Velázquez S; Camarasa MJ
J Med Chem; 2008 Sep; 51(18):5823-32. PubMed ID: 18707089
[TBL] [Abstract][Full Text] [Related]
29. Cytogenetics of Werner's syndrome cultured skin fibroblasts: variegated translocation mosaicism.
Salk D; Au K; Hoehn H; Martin GM
Cytogenet Cell Genet; 1981; 30(2):92-107. PubMed ID: 7273860
[TBL] [Abstract][Full Text] [Related]
30. Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766): in vitro and in vivo antiviral activity and mechanism of action.
Reefschlaeger J; Bender W; Hallenberger S; Weber O; Eckenberg P; Goldmann S; Haerter M; Buerger I; Trappe J; Herrington JA; Haebich D; Ruebsamen-Waigmann H
J Antimicrob Chemother; 2001 Dec; 48(6):757-67. PubMed ID: 11733458
[TBL] [Abstract][Full Text] [Related]
31. Development of both colorimetric and fluorescence heparinase activity assays using fondaparinux as substrate.
Schiemann S; Lühn S; Alban S
Anal Biochem; 2012 Aug; 427(1):82-90. PubMed ID: 22579846
[TBL] [Abstract][Full Text] [Related]
32. [Werner's syndrome associated with meningioma: case report].
Kawauchi M; Gibo H; Kobayashi S; Sugita K
No Shinkei Geka; 1988 Feb; 16(2):189-94. PubMed ID: 3285233
[TBL] [Abstract][Full Text] [Related]
33. The Artemisinin Derivative Artemisone Is a Potent Inhibitor of Human Cytomegalovirus Replication.
Oiknine-Djian E; Weisblum Y; Panet A; Wong HN; Haynes RK; Wolf DG
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712656
[TBL] [Abstract][Full Text] [Related]
34. LMNA mutations in atypical Werner's syndrome.
Chen L; Lee L; Kudlow BA; Dos Santos HG; Sletvold O; Shafeghati Y; Botha EG; Garg A; Hanson NB; Martin GM; Mian IS; Kennedy BK; Oshima J
Lancet; 2003 Aug; 362(9382):440-5. PubMed ID: 12927431
[TBL] [Abstract][Full Text] [Related]
35. [Carboxy mimetic derivatives of nucleic acid polymeric backbones inhibiting human cytomegalovirus. 1. In vitro microbicidal effect].
Serbin AV; Karaseva EN; Fedorova NE; Pavlova MV; Klimova EV; Leont'eva MV; Kushch AA
Antibiot Khimioter; 2007; 52(11-12):8-13. PubMed ID: 19275050
[TBL] [Abstract][Full Text] [Related]
36. Elevation of urinary hyaluronic acid in Werner's syndrome and progeria.
Kieras FJ; Brown WT; Houck GE; Zebrower M
Biochem Med Metab Biol; 1986 Dec; 36(3):276-82. PubMed ID: 3801210
[TBL] [Abstract][Full Text] [Related]
37. Growth hormone binding protein in Werner's syndrome.
Hattori N; Hino M; Ikekubo K; Ishihara T; Moridera K; Kurahachi H
Clin Endocrinol (Oxf); 1992 Apr; 36(4):351-3. PubMed ID: 1424167
[TBL] [Abstract][Full Text] [Related]
38. Artesunate-derived monomeric, dimeric and trimeric experimental drugs - Their unique mechanistic basis and pronounced antiherpesviral activity.
Hahn F; Fröhlich T; Frank T; Bertzbach LD; Kohrt S; Kaufer BB; Stamminger T; Tsogoeva SB; Marschall M
Antiviral Res; 2018 Apr; 152():104-110. PubMed ID: 29458133
[TBL] [Abstract][Full Text] [Related]
39. NMR structural determination of unique invertebrate glycosaminoglycans endowed with medical properties.
Pomin VH
Carbohydr Res; 2015 Sep; 413():41-50. PubMed ID: 26083200
[TBL] [Abstract][Full Text] [Related]
40. Validation and Characterization of Five Distinct Novel Inhibitors of Human Cytomegalovirus.
Kapoor A; Ghosh AK; Forman M; Hu X; Ye W; Southall N; Marugan J; Keyes RF; Smith BC; Meyers DJ; Ferrer M; Arav-Boger R
J Med Chem; 2020 Apr; 63(8):3896-3907. PubMed ID: 32191456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
